BrUOG 416

Phase I and II Study of NovoTTF-200A and Pembrolizumab in Newly Diagnosed Melanoma Brain Metastasis
Status:

Pending

Trial Type:

Contact:

Eric Wong, MD
ewong1@brownhealth.org